• Indian Indices
  • Global Indices
  • Commodities
  • Currency
Sensex
  • Sensex
  • Nifty
{{x.close_price| number:2}} {{x.netchg| number:2}} ({{x.perchg | number:2}}%)
Open - {{x.open | number:2}}
Prev Close - {{x.prevclose|number:2}}
Today's High - {{x.high|number:2}}
Today's Low - {{x.low|number:2}}
Advances/Declines (30 Companies)
  • 1D
  • 1W
  • 1M
  • 1Yr
  • 5Yr
{{x.upd_time}}
FTSE 100
  • FTSE 100
  • DJIA
  • NIKKEI 225
  • HANG SENG
{{x.Date}}
{{x.close| number:2}} {{x.Chg | number:2}} ({{x.PChg | number:2}}%)
Open - {{x.close | number:2}}
Prev Close - {{x.PrevClose|number:2}}
Gold
  • Gold
  • Silver
  • Crude Oil
  • Copper
{{x.Trd_Date}} ( {{x.Time}} )
{{x.ClosePrice| number:2}} {{x.change| number:2}} ({{x.perchange | number:2}}%)
Exchange - MCX
Open - {{x.Open|number:2}}
Exp Date - {{x.Exp_Date}}
Today's High - {{x.High|number:2}}
Prev. Close - {{x.PrevClose|number:2}}
Today's Low - {{x.Low|number:2}}
USDINR
  • USDINR
  • GBPINR
  • EURINR
  • JPYINR
{{x.Lasttrdtime}} ( {{x.Time}} )
{{x.ltp| number:2}} {{x.PriceDiff| number:2}} ({{x.PerChange | number:2}}%)
Exchange - NSE
Open - {{x.Open|number:2}}
Exp Date - {{x.Expirydate}}
Today's High - {{x.High|number:2}}
Prev. Close - {{x.PrevPrice|number:2}}
Today's Low - {{x.Low|number:2}}
As On 21-Jan-2021 13:59 PM
50,111.17
319.05 (0.64%)
NIFTY
14,726.95
82.25 (0.56%)
SENSEX
    No Companies Visited

Back to news list
  • Gland Pharma IPO subscribed over two times

    The issue received bids for 6.21 crore shares as against 3.02 crore shares on offer.

    The initial public offer (IPO) of Gland Pharma received bids for 6.21 crore shares on Wednesday, 11 November 2020, as against 3.02 crore shares on offer, as per the National Stock Exchange of India (NSE) website data at 17:30 IST. The issue was subscribed 2.06 times.

    The issue opened for bidding on Monday, 9 November 2020 and it will close today, 11 November 2020. The price band for the IPO was set at Rs 1490-1500 per share.

    The IPO consisted of fresh issue of shares amounting to Rs 1250 crore and an offer of sale of 3,48,63,635 shares by the selling shareholders.

    Ahead of the IPO, the Hyderabad-based generic injectables-focused company allotted 1,29,59,089 shares to 70 anchor investors at Rs 1,500 per share aggregating to Rs 1,943.86 crore.

    Overseas investors included SmallCap World Fund INC, Government of Singapore, The Nomura Trust And Banking Co and Goldman Sachs.

    Out of the total 1,29,59,089 shares allotted to anchor investors, the company allocated 43,19,700 shares (or 33.33% of the total anchor allotment portion) to 18 domestic mutual funds through a total of 77 schemes.

    The proceeds of the offer for sale shall be received by the selling shareholders. The company proposes to utilise the net proceeds of the fresh issue towards funding incremental working capital requirements; funding capital expenditure requirements; and general corporate purposes.

    The company recorded net profit of Rs 313.59 crore and total income of Rs 916.28 crore in the quarter ended on 30 June 2020.

    Hyderabad-based Gland Pharma is one of the largest and fastest growing injectable-focused companies, with a global footprint across 60 countries, including the United States, Europe, Canada, Australia, India and other markets. It operates primarily under a business to business (B2B) model and it engaged in development, manufacturing and marketing of complex injectables. The company is promoted by Shanghai Fosun Pharma, a global pharmaceutical major.

    Back to news list
Previous Stories :
More

Quick Links

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

The power of the database is harnessed by our fired-up reporters to generate interesting ideas. The reader-friendly presentation of the idea, supplemented by relevant data and information, can be accessed online through Capita Telefolio and Telefolio Gold. These ideas are used by individual investors as well as institutional investors to do further research and stay ahead.

Capital Market Publishers India Pvt. Ltd.

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071.
91-22-25229720
91-22-25230011
Kindly note www.capitalmarket.com does not send any mobile SMS, whatsapp or twitter messages
giving any kind of stock recommendations.
For Capital Market Magazine queries mail to : subscription@capitalmarket.com
For Capital Market Online Products related queries mail to : financeshop@capitalmarket.com
For any other Capital Market Website related Queries mail to : info@capitalmarket.com
To advertise on Capital Market Websites & Capital Market Fortnightly magazine mail to : advt@capitalmarket.com
Flash News 21-Jan-2021
  •  ( 13:39) European markets edge higher amid optimism as Biden’s presidency begins  
  •  ( 13:39) Barometers extends massive gains; positive market breadth  
  •  ( 12:40) India VIX falls 4.07%  
  •  ( 12:38) Indices continue to hit new record highs; positive market breadth  
  •  ( 12:38) HDFC AMC Q3 PAT up 4.73% Y-o-Y to Rs 369.26 cr  
  •  ( 12:38) VST Industries consol. Q3 PAT down 9.5% Y-o-Y to Rs 73.71 cr  
  •  ( 12:27) Syngene International Q3 PAT rises 11% YoY to Rs 102 cr  
  •  ( 11:02) Havells India consol. Q3 PAT up 74.5% Y-o-Y to Rs 350.14 cr  
  •  ( 10:40) GMM Pfaudler consol. Q3 PAT up 9.8% Y-o-Y to Rs 23.11 cr  
  •  ( 10:31) Indices at day's high  
  •  ( 10:20) Bajaj Finserv Q3 PAT up 14.59% Y-o-Y to Rs 1,289.96 cr  
  •  ( 09:58) HDFC AMC Q3 PAT up 4.73% Y-o-Y to Rs 369.26 cr  
  •  ( 09:32) Strong market breadth  
  •  ( 09:21) Sensex stikes record high above 50,000   
  •  ( 09:20) VST Industries consol. Q3 PAT down 9.5% Y-o-Y to Rs 73.71 cr  
  •  ( 09:19) Market opens on firm note  
  •  ( 08:32) Asian stocks trading higher  
  •  ( 07:59) Joe Biden sworn in as 46th US president   
  •  ( 07:58) S&P 500, Nasdaq scale record highs  
Show News
21 January 2021 13:58
2748.65
(1.88 %)
690.45
(2.25 %)
3751.05
(3.13 %)
5202.00
(4.43 %)
9330.25
(4.38 %)
588.20
(-1.34 %)
5080.20
(0.03 %)
2662.90
(-0.96 %)
1001.15
(0.23 %)
1479.80
(-0.75 %)
2395.40
(1.70 %)
558.25
(1.35 %)
961.00
(1.42 %)
1345.90
(0.48 %)
217.20
(-0.18 %)
1893.90
(0.53 %)
1386.30
(0.31 %)
823.85
(-0.04 %)
8250.25
(1.32 %)
17798.75
(0.68 %)
98.40
(0.10 %)
97.30
(-1.57 %)
195.40
(-0.46 %)
2114.35
(2.90 %)
301.10
(-0.48 %)
589.10
(-0.90 %)
3283.00
(-0.76 %)
1008.80
(-1.02 %)
1526.65
(-0.28 %)
5605.55
(1.08 %)
Sensex 5min and Nifty 15min delayed as on .
Show Ticker
Rotate your device

Rotate your device

For the best experience please go back to portrait mode.